SCHEMBL9707557

SCHEMBL9707557

CC(C)Cn1c(=O)[nH]c(=O)c2c1nc(C(C)C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
THRB P10828 1/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 3/20 0.43
MEN1 O00255 8/20 0.43
KMT2A Q03164 8/20 0.43
PKM P14618 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ALOX15 P16050 1/20 0.43
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
GAA P10253 1/20 0.41
CXCL8 P10145 1/20 0.40
NOD2 Q9HC29 1/20 0.40
NOD1 Q9Y239 1/20 0.40
MCL1 Q07820 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TSHR P16473 1/20 0.40
USP1 O94782 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707643 0.92 MEN1 (0.48) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9707464 0.91 MEN1 (0.45) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9708151 0.91 ALDH1A1 (0.46) ALDH1A1THRBKDM4EHPGDMEN1
SCHEMBL9708303 0.90 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9708130 0.90 CXCL8 (0.49) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9707498 0.89 MEN1 (0.46) ALDH1A1THRBKDM4EHPGDMEN1
SCHEMBL9707717 0.89 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9708857 0.89 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9708300 0.88 MEN1 (0.42) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9708184 0.88 MEN1 (0.47) ALDH1A1THRBKDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed